Advanced Therapies UK Congress and Expo 2026
Date: Tue, Mar 17, 2026 – Wed, Mar 18, 2026
No content found
Advanced Therapies UK Congress and Expo, held on 17–18 March 2026 at ExCeL London, United Kingdom, focuses on the full development cycle of cell and gene therapies, including ATMP innovation, clinical strategies, regulatory frameworks, manufacturing scale‑up, market access and patient delivery. The event brings together 3,300+ global executives to explore cutting‑edge technologies and solutions across the therapy value chain with participation from pharmaceutical, biotech, academic, clinical and regulatory communities. Featuring 300+ expert speakers, 200+ exhibitors and presentations from 75+ start‑ups, the congress supports knowledge exchange, networking and advancement of next‑generation therapies. Organizer: Terrapinn.
Range of Exhibition
- Cell & Gene Therapy Platforms: Cell and gene therapy systems, novel gene delivery technologies, immunotherapy products.
- Therapy Development & Manufacturing: Automation and closed systems, continuous manufacturing, viral vector and bioprocessing solutions.
- Clinical & Regulatory Solutions: Clinical trial support, regulatory compliance frameworks, market access, reimbursement strategies.
- Precision Medicine & Immunotherapy: CAR‑T, NK, gamma‑delta cells, precision patient stratification, immunotherapy advances.
- Supply Chain & Logistics: Cold chain logistics, distribution solutions, point‑of‑care delivery innovations.
Conference Themes & Discussion Topics
- Clinical Success & Access: Ensuring clinical outcomes, cross‑border healthcare frameworks, reimbursement & pricing strategies, regulatory challenges.
- Cell & Gene Therapy Techniques: Autologous vs allogeneic therapies, tackling solid tumours, stem cell and regenerative approaches, cord blood advancements.
- Next‑Gen Therapy Technologies: Novel gene therapies, immunogenicity solutions, rare diseases applications, gene editing, precision medicine.
- Manufacturing & Scale‑Up: Automation and closed systems, commercial production scaling, cost efficiencies, outsourcing vs in‑house models.
- Supply Chain & Patient Delivery: Logistics, distribution, cold chain management, patient experience and care pathways.
- Innovation & Market Landscape: Start‑up showcases, investor perspectives, academic research breakthroughs.
Target Audience
Biotech executives, pharmaceutical leaders, gene and cell therapy researchers, clinical scientists, biotech investors, regulators, health technology assessors, manufacturing specialists, healthcare strategists.
Related Events
